Human Gene mir-34 (uc009vmq.3) Description and Page Index
  Description: Homo sapiens microRNA mir-34.
Transcript (Including UTRs)
   Position: hg19 chr1:9,208,346-9,242,451 Size: 34,106 Total Exon Count: 2 Strand: -
Coding Region
   Position: hg19 chr1:9,211,782-9,242,345 Size: 30,564 Coding Exon Count: 2 

Page IndexSequence and LinksGene AllelesMicroarray ExpressionRNA StructureOther Species
mRNA DescriptionsOther NamesModel InformationMethods
Data last updated: 2013-06-14

-  Sequence and Links to Tools and Databases
 
Genomic Sequence (chr1:9,208,346-9,242,451)mRNA (may differ from genome)Protein (130 aa)
Gene SorterGenome BrowserOther Species FASTATable SchemaCGAPExonPrimer
GeneCardsMGIPubMedStanford SOURCEWikipedia

+  Common Gene Haplotype Alleles
  Press "+" in the title bar above to open this section.

+  Microarray Expression Data
  Press "+" in the title bar above to open this section.

-  mRNA Secondary Structure of 3' and 5' UTRs
 
RegionFold EnergyBasesEnergy/Base
Display As
5' UTR -43.12106-0.407 Picture PostScript Text
3' UTR -1393.743436-0.406 Picture PostScript Text

The RNAfold program from the Vienna RNA Package is used to perform the secondary structure predictions and folding calculations. The estimated folding energy is in kcal/mol. The more negative the energy, the more secondary structure the RNA is likely to have.

-  Orthologous Genes in Other Species
  Orthologies between human, mouse, and rat are computed by taking the best BLASTP hit, and filtering out non-syntenic hits. For more distant species reciprocal-best BLASTP hits are used. Note that the absence of an ortholog in the table below may reflect incomplete annotations in the other species rather than a true absence of the orthologous gene.
MouseRatZebrafishD. melanogasterC. elegansS. cerevisiae
No orthologNo orthologNo orthologNo orthologNo orthologNo ortholog
      
      
      
      
      

-  Descriptions from all associated GenBank mRNAs
  EF570048 - Homo sapiens microRNA 34a (MIRN34A) precursor RNA, complete sequence.
JD414693 - Sequence 395717 from Patent EP1572962.
JD256509 - Sequence 237533 from Patent EP1572962.
JD256510 - Sequence 237534 from Patent EP1572962.
JD340970 - Sequence 321994 from Patent EP1572962.
JD337828 - Sequence 318852 from Patent EP1572962.
JD291480 - Sequence 272504 from Patent EP1572962.
JD249820 - Sequence 230844 from Patent EP1572962.
JD148289 - Sequence 129313 from Patent EP1572962.
JD463802 - Sequence 444826 from Patent EP1572962.
EF592573 - Homo sapiens microRNA-34a primary transcript, complete sequence.
EF609116 - Homo sapiens precursor microRNA mir-34a, complete sequence.
CS266366 - Sequence 58 from Patent WO2005118806.
DL076528 - METHODS AND COMPOSITIONS INVOLVING MicroRNA.
DM004178 - METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
FU261115 - MICRORNA EXPRESSION ABNORMALITIES IN PANCREATIC ENDOCRINE AND ACINAR TUMORS.
FU763617 - MICRORNA FINGERPRINTS DURING HUMAN MEGAKARYOCYTOPOIESIS.
FV525818 - Nucleic acid controling mast cell degranulation.
FW421520 - METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
FW504782 - COMPOSITIONS COMPRISING MIR34 THERAPEUTIC AGENTS FOR TREATING CANCER.
HI508133 - Sequence 2 from Patent EP2152722.
HV304516 - JP 2009531018-A/83: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS, PROGNOSIS AND TREATMENT OF LUNG CANCER.
HV305014 - JP 2009531019-A/83: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HW102015 - JP 2013500034-A/142: Use of microRNA for treating diseases associated with a dysfunction of the cilia in multiciliated epithelial cells.
HW119223 - JP 2013046612-A/83: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HW367391 - JP 2012228254-A/58: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HW411784 - JP 2014000079-A/58: METHODS AND COMPOSITIONS INVOLVING MicroRNA.
HW505133 - JP 2014502606-A/35: MELANOMA TREATMENTS.
HW589552 - JP 2013121348-A/83: MICRORNA FINGERPRINTS DURING HUMAN MEGAKARYOCYTOPOIESIS.
HW674130 - JP 2014217381-A/58: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ067072 - JP 2014012020-A/58: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ408233 - JP 2015528002-A/830: CHIRAL CONTROL.
HZ413356 - JP 2014060993-A/83: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HZ427496 - JP 2014217384-A/58: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ428299 - JP 2014217385-A/58: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ429102 - JP 2014217386-A/58: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ429905 - JP 2014217387-A/58: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ501567 - JP 2016025853-A/83: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HZ769162 - JP 2014223080-A/58: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
JA058556 - Sequence 58 from Patent EP2298893.
JA059359 - Sequence 58 from Patent EP2298894.
JA073682 - Sequence 58 from Patent EP2281887.
JA104819 - Sequence 58 from Patent EP2302051.
JA106159 - Sequence 58 from Patent EP2302052.
JA106962 - Sequence 58 from Patent EP2302053.
JA107765 - Sequence 58 from Patent EP2302054.
JA108568 - Sequence 58 from Patent EP2302055.
JA109371 - Sequence 58 from Patent EP2302056.
JA191887 - Sequence 58 from Patent EP2290066.
JA192786 - Sequence 58 from Patent EP2290067.
JA193685 - Sequence 58 from Patent EP2290068.
JA194584 - Sequence 58 from Patent EP2290069.
JA195483 - Sequence 58 from Patent EP2290070.
JA196382 - Sequence 58 from Patent EP2290071.
JA197281 - Sequence 58 from Patent EP2290072.
JA198180 - Sequence 58 from Patent EP2290073.
JA199079 - Sequence 58 from Patent EP2290074.
JA199978 - Sequence 58 from Patent EP2290075.
JA200877 - Sequence 58 from Patent EP2290076.
JA217999 - Sequence 58 from Patent EP2281888.
JA226150 - Sequence 58 from Patent EP2292755.
JA229005 - Sequence 58 from Patent EP2292756.
JA257276 - Sequence 58 from Patent EP2284265.
JA278556 - Sequence 58 from Patent EP2281886.
JA284442 - Sequence 58 from Patent EP2281889.
JA292495 - Sequence 58 from Patent EP2287303.
JA317681 - Sequence 58 from Patent EP2314688.
JA374740 - Sequence 58 from Patent EP2322616.
JA525933 - Sequence 83 from Patent EP2369011.
JA526440 - Sequence 83 from Patent EP2369012.
JA526947 - Sequence 83 from Patent EP2369013.
JA535876 - Sequence 83 from Patent EP2371971.
JA787881 - Sequence 83 from Patent EP2479285.
JA788379 - Sequence 83 from Patent EP2479286.
JA810713 - Sequence 83 from Patent EP2468890.
JA811211 - Sequence 83 from Patent EP2468891.
JA811709 - Sequence 83 from Patent EP2468893.
JA812207 - Sequence 83 from Patent EP2468894.
JA812705 - Sequence 83 from Patent EP2468895.
JA813203 - Sequence 83 from Patent EP2468896.
JA813701 - Sequence 83 from Patent EP2468897.
JA814199 - Sequence 83 from Patent EP2468898.
JA814697 - Sequence 83 from Patent EP2468899.
JA816940 - Sequence 83 from Patent EP2468892.
JA825752 - Sequence 83 from Patent EP2471956.
JA826250 - Sequence 83 from Patent EP2471958.
JB024537 - Sequence 83 from Patent EP2505668.
JB025035 - Sequence 83 from Patent EP2505669.
JB079422 - Sequence 83 from Patent EP2487252.
JB079920 - Sequence 83 from Patent EP2487253.
JB080418 - Sequence 83 from Patent EP2487254.
JB080916 - Sequence 83 from Patent EP2487255.
JB081414 - Sequence 83 from Patent EP2487256.
JB081912 - Sequence 83 from Patent EP2487257.
JB082410 - Sequence 83 from Patent EP2487258.
JB082908 - Sequence 83 from Patent EP2487259.
JB083406 - Sequence 83 from Patent EP2487260.
JB083904 - Sequence 83 from Patent EP2487261.
JB084402 - Sequence 83 from Patent EP2487262.
JB084900 - Sequence 83 from Patent EP2487263.
JB087578 - Sequence 83 from Patent EP2502630.
JB147782 - Sequence 83 from Patent EP2484782.
JB148280 - Sequence 83 from Patent EP2484783.
JB153005 - Sequence 83 from Patent EP2514433.
JB153503 - Sequence 83 from Patent EP2514434.
JB622092 - Sequence 83 from Patent EP2586454.
JB622590 - Sequence 83 from Patent EP2586455.
JC001653 - Sequence 83 from Patent EP2591794.
JC037592 - Sequence 120 from Patent EP2643479.
JC221583 - Sequence 58 from Patent EP2471923.
JC268149 - Sequence 58 from Patent EP2471924.
JC340457 - Sequence 58 from Patent EP2471922.
JC469703 - Sequence 58 from Patent EP2471921.
JC572000 - Sequence 14 from Patent EP2759595.
JC990492 - Sequence 58 from Patent EP2808390.
LF132449 - JP 2016506923-A/14: Composition comprising an encapsulated antagomir.
LF714595 - JP 2016165292-A/58: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
LF856529 - JP 2015142597-A/58: METHODS AND COMPOSITIONS INVOLVING MicroRNA.
LG051567 - KR 1020150036642-A/833: CHIRAL CONTROL.
LG162313 - KR 1020160018451-A/14: Composition comprising an encapsulated antagomir.
LP010721 - Sequence 26 from Patent EP2977463.
LZ228144 - JP 2017524341-A/2: HYBRID TRNA/PRE-MIRNA MOLECULES AND METHODS OF USE.
MS810731 - Sequence 1 from Patent EP3142707.
CS266560 - Sequence 252 from Patent WO2005118806.
DL076722 - METHODS AND COMPOSITIONS INVOLVING MicroRNA.
DM004372 - METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
FW421714 - METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HW367585 - JP 2012228254-A/252: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HW411978 - JP 2014000079-A/252: METHODS AND COMPOSITIONS INVOLVING MicroRNA.
HW674324 - JP 2014217381-A/252: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ067266 - JP 2014012020-A/252: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ427690 - JP 2014217384-A/252: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ428493 - JP 2014217385-A/252: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ429296 - JP 2014217386-A/252: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ430099 - JP 2014217387-A/252: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ769356 - JP 2014223080-A/252: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
JA058750 - Sequence 252 from Patent EP2298893.
JA059553 - Sequence 252 from Patent EP2298894.
JA073876 - Sequence 252 from Patent EP2281887.
JA105013 - Sequence 252 from Patent EP2302051.
JA106353 - Sequence 252 from Patent EP2302052.
JA107156 - Sequence 252 from Patent EP2302053.
JA107959 - Sequence 252 from Patent EP2302054.
JA108762 - Sequence 252 from Patent EP2302055.
JA109565 - Sequence 252 from Patent EP2302056.
JA192081 - Sequence 252 from Patent EP2290066.
JA192980 - Sequence 252 from Patent EP2290067.
JA193879 - Sequence 252 from Patent EP2290068.
JA194778 - Sequence 252 from Patent EP2290069.
JA195677 - Sequence 252 from Patent EP2290070.
JA196576 - Sequence 252 from Patent EP2290071.
JA197475 - Sequence 252 from Patent EP2290072.
JA198374 - Sequence 252 from Patent EP2290073.
JA199273 - Sequence 252 from Patent EP2290074.
JA200172 - Sequence 252 from Patent EP2290075.
JA201071 - Sequence 252 from Patent EP2290076.
JA218193 - Sequence 252 from Patent EP2281888.
JA226344 - Sequence 252 from Patent EP2292755.
JA229199 - Sequence 252 from Patent EP2292756.
JA257470 - Sequence 252 from Patent EP2284265.
JA278750 - Sequence 252 from Patent EP2281886.
JA284636 - Sequence 252 from Patent EP2281889.
JA292689 - Sequence 252 from Patent EP2287303.
JA317875 - Sequence 252 from Patent EP2314688.
JA374934 - Sequence 252 from Patent EP2322616.
JC221777 - Sequence 252 from Patent EP2471923.
JC268343 - Sequence 252 from Patent EP2471924.
JC340651 - Sequence 252 from Patent EP2471922.
JC469897 - Sequence 252 from Patent EP2471921.
JC990686 - Sequence 252 from Patent EP2808390.
LF714789 - JP 2016165292-A/252: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
LF856723 - JP 2015142597-A/252: METHODS AND COMPOSITIONS INVOLVING MicroRNA.
FW364245 - Oligonucleotides for modulating target RNA activity.
FW504815 - COMPOSITIONS COMPRISING MIR34 THERAPEUTIC AGENTS FOR TREATING CANCER.
HI508166 - Sequence 35 from Patent EP2152722.
HI560876 - Sequence 91 from Patent EP2190992.
HI965152 - Sequence 437 from Patent WO2010139812.
HI965788 - Sequence 108 from Patent WO2010139811.
HI966654 - Sequence 108 from Patent WO2010139810.
HV593977 - JP 2010538653-A/91: MIRNA EXPRESSION IN HUMAN PERIPHERAL BLOOD MICROVESICLES AND USES THEREOF.
HV595154 - JP 2010539959-A/535: Micromirs.
HW101963 - JP 2013500034-A/90: Use of microRNA for treating diseases associated with a dysfunction of the cilia in multiciliated epithelial cells.
HW505500 - JP 2014502606-A/402: MELANOMA TREATMENTS.
HW913253 - JP 2015504307-A/13: METHODS OF DIAGNOSING AND TREATING IDIOPATHIC PULMONARY FIBROSIS.
HZ074021 - JP 2013535982-A/112: Single-Stranded RNAi Agents Containing an Internal, Non-Nucleic Acid Spacer.
HZ083046 - JP 2015513906-A/403: Stem Cell Microparticles.
HZ157711 - JP 2015130862-A/535: Micromirs.
HZ186558 - JP 2015146814-A/307: Oligonucleotides for modulating target RNA activity.
HZ436827 - JP 2015529450-A/403: Stem Cell Microparticles.
HZ466305 - JP 2015531594-A/8: METHODS OF GENERATING MESENCHYMAL STEM CELLS WHICH SECRETE NEUROTROPHIC FACTORS.
HZ480234 - JP 2015535430-A/740: TERMINALLY MODIFIED RNA.
HZ790165 - JP 2016504050-A/1910: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
JA287408 - Sequence 90 from Patent WO2011015720.
JA401190 - Sequence 437 from Patent WO2011080318.
JA402168 - Sequence 437 from Patent WO2011080315.
JA403175 - Sequence 437 from Patent WO2011080316.
JA405806 - Sequence 437 from Patent EP2336353.
JA426978 - Sequence 311 from Patent WO2011072177.
JA429332 - Sequence 437 from Patent WO2011095623.
JA660623 - Sequence 77 from Patent WO2011131354.
JB022201 - Sequence 43 from Patent WO2013026685.
JB022754 - Sequence 8 from Patent WO2013026684.
JB074834 - Sequence 94 from Patent WO2012168448.
JB620062 - Sequence 42 from Patent WO2013063544.
JB620196 - Sequence 176 from Patent WO2013063544.
JB624271 - Sequence 91 from Patent EP2610342.
JB778634 - Sequence 13 from Patent WO2013078283.
JB982240 - Sequence 18 from Patent WO2013190091.
JC172031 - Sequence 403 from Patent WO2013150303.
JC244447 - Sequence 67 from Patent WO2012020308.
JC512897 - Sequence 3150 from Patent WO2014113089.
JC572031 - Sequence 45 from Patent EP2759595.
JC572842 - Sequence 403 from Patent WO2014125276.
JC582530 - Sequence 403 from Patent WO2014125277.
JE954226 - Sequence 403 from Patent WO2015052526.
JE955979 - Sequence 403 from Patent WO2015052527.
JE978632 - Sequence 77 from Patent EP2865765.
LF132480 - JP 2016506923-A/45: Composition comprising an encapsulated antagomir.
LF137731 - JP 2016507550-A/403: Method of Producing Microparticles.
LF160053 - JP 2016513950-A/119: Oligomers with improved off-target profile.
LF162696 - JP 2016513095-A/403: Stem Cell Microparticles and miRNA.
LF953448 - JP 2016534103-A/403: Stem Cell Microparticles and miRNA.
LG005793 - KR 1020150004822-A/403: STEM CELL MICROPARTICLES.
LG053489 - KR 1020150059168-A/403: STEM CELL MICROPARTICLES.
LG162344 - KR 1020160018451-A/45: Composition comprising an encapsulated antagomir.
LG240728 - KR 1020160035087-A/403: STEM CELL MICROPARTICLES AND MIRNA.
LP726414 - Sequence 108 from Patent EP2883966.
LP818684 - Sequence 108 from Patent EP3296406.
LP938626 - Sequence 108 from Patent EP3184651.
LQ070485 - Sequence 809 from Patent EP2964234.
LQ417667 - Sequence 3 from Patent WO2016125163.
LQ441087 - Sequence 94 from Patent EP3029157.
LQ731203 - Sequence 39 from Patent EP3325624.
LV470813 - JP 2016534036-A/403: Stem Cell Microparticles and miRNA.
LY405219 - KR 1020160117535-A/524: POLY OLIGOMER COMPOUND WITH BIOCLEAVABLE CONJUGATES.
LZ233915 - JP 2017184756-A/307: Oligonucleotides for modulating target RNA activity.
MA260458 - JP 2017505623-A/524: POLY OLIGOMER COMPOUND WITH BIOCLEAVABLE CONJUGATES.
MS673205 - Sequence 8 from Patent EP3135774.
MS833386 - Sequence 91 from Patent EP3112464.
MS834291 - Sequence 437 from Patent EP3112479.
MS901570 - Sequence 43 from Patent EP3156505.
LQ417666 - Sequence 2 from Patent WO2016125163.
AY194151 - Homo sapiens microRNA miR-34, complete sequence.
CQ873674 - Sequence 93 from Patent WO2004076622.
CS548417 - Sequence 1447 from Patent EP1777301.
DD413511 - Regulation of Mammalian Cells.
FV524273 - Nucleic acid controling mast cell degranulation.
FW312159 - DETECTING NUCLEIC ACIDS.
FZ436961 - JP 2011501966-A/8: PROCESS FOR MONITORING COLORECTAL CANCER.
HI463857 - Sequence 2 from Patent EP2124967.
HV335759 - JP 2011093892-A/2: Tumor proliferation suppressor comprising tumor suppressive micro RNA.
HV534432 - WO 2011111715-A/948: Nucleic acid for controlling cell cycle.
JC265631 - Sequence 1 from Patent WO2013017542.
JC334246 - Sequence 164 from Patent EP2487240.
JE869360 - Sequence 1 from Patent WO2015131115.
LF636227 - JP 2016519076-A/1: COMBINATION CANCER TREATMENTS UTILIZING MICRORNA AND EGFR-TKI INHIBITORS.
LF838608 - JP 2016530232-A/3: Biomarkers of miR-34 Activity.
LG134384 - KR 1020150131312-A/1: COMBINATION CANCER TREATMENTS UTILIZING MICRORNAS AND EGFR-TKI INHIBITORS.
LP637005 - Sequence 55 from Patent EP2848702.
LQ069373 - Sequence 1 from Patent WO2015153757.
LY409556 - KR 1020160122850-A/1: SORAFENIB-MICRORNA COMBINATION THERAPY FOR LIVER CANCER.
MA264538 - JP 2017507955-A/1: SORAFENIB-MICRORNA COMBINATION THERAPY FOR LIVER CANCER.
AJ550399 - Homo sapiens microRNA mir-34.
CS166329 - Sequence 40 from Patent WO2005078096.
CS265299 - Sequence 41 from Patent EP1627925.
CS444354 - Sequence 41 from Patent WO2006108473.
DI488453 - KR 1020140147919-A/1: Biomaker miR-451 for distinguishing non-alcoholic steatohepatitis.
DI488460 - KR 1020140147920-A/1: Biomaker miR-34a for distinguishing non-alcoholic steatohepatitis.
DI488467 - KR 1020140147921-A/1: Biomaker miR-494-3p for distinguishing non-alcoholic steatohepatitis.
DJ003842 - Method for predicting or identifying target mRNAs of functional RNAs and use thereof.
DJ027121 - Method for predicting or identifying target mRNAs of functional RNAs and use thereof.
DL231871 - Method for the determination of cellular transcriptional regulation.
FU261388 - MICRORNA EXPRESSION ABNORMALITIES IN PANCREATIC ENDOCRINE AND ACINAR TUMORS.
FU763890 - MICRORNA FINGERPRINTS DURING HUMAN MEGAKARYOCYTOPOIESIS.
FW362676 - MICRORNA EXPRESSION SIGNATURE FOR PREDICTING SURVIVAL AND METASTASES IN HEPATOCELLULAR CARCINOMA.
FW364244 - Oligonucleotides for modulating target RNA activity.
FW504781 - COMPOSITIONS COMPRISING MIR34 THERAPEUTIC AGENTS FOR TREATING CANCER.
FZ414384 - WO 2011007815-A/274: A method for screening a food which promotes production of milk having immunoregulating effect.
HH981318 - Sequence 78 from Patent EP1723162.
HI377383 - Sequence 10 from Patent EP2087135.
HI508132 - Sequence 1 from Patent EP2152722.
HI528954 - Sequence 34 from Patent EP2142659.
HI539279 - Sequence 103 from Patent EP2160477.
HI560875 - Sequence 90 from Patent EP2190992.
HI929402 - Sequence 9 from Patent EP2258863.
HI965153 - Sequence 438 from Patent WO2010139812.
HI966097 - Sequence 417 from Patent WO2010139811.
HI966963 - Sequence 417 from Patent WO2010139810.
HV304789 - JP 2009531018-A/356: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS, PROGNOSIS AND TREATMENT OF LUNG CANCER.
HV305287 - JP 2009531019-A/356: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HV321528 - JP 2011072229-A/35: Diagnosis and therapeutic choice of hypopharyngeal cancer using micro RNA as biomarker.
HV511981 - JP 2011520454-A/96: Methods for Assessing Colorectal Cancer and Compositions for use therein.
HV540977 - WO 2011125469-A/21: A recombinant vaccinia virus regulated by miRNA and use thereof.
HV543935 - JP 2011217617-A/46: Method for testing fibrosis of chronic liver diseases using miRNAs.
HV582960 - JP 2010527616-A/101: Micro-RNA Scaffolds and Non-Naturally Occurring Micro-RNAS.
HV593976 - JP 2010538653-A/90: MIRNA EXPRESSION IN HUMAN PERIPHERAL BLOOD MICROVESICLES AND USES THEREOF.
HV595153 - JP 2010539959-A/534: Micromirs.
HV753278 - JP 2012509865-A/1: Compositions and methods for treating retrovirus infections.
HV753797 - JP 2012509675-A/35: COMPOSITIONS AND METHODS FOR DETECTING SMALL RNAS, AND USES THEREOF.
HV821912 - JP 2011140513-A/274: An Immunostimulating pharmaceutical composition, and a method for producing the immunostimulating pharmaceutical composition.
HV954026 - JP 2012518421-A/938: METHODS OF DETECTING LUNG CANCER.
HV956208 - JP 2012519484-A/5: LIVE ATTENUATED INFLUENZA VIRUS VACCINES COMPRISING MICRORNA RESPONSE ELEMENTS.
HW060376 - JP 2012527478-A/40: Identification of MicroRNAs Involved in Post-Myocardial Infarction Remodeling and Heart Failure.
HW101911 - JP 2013500034-A/38: Use of microRNA for treating diseases associated with a dysfunction of the cilia in multiciliated epithelial cells.
HW119496 - JP 2013046612-A/356: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HW248829 - JP 2013514372-A/28: MICRO-RNA REGULATION IN ISCHEMIA AND ISCHEMIA-REPERFUSION INJURY.
HW505322 - JP 2014502606-A/224: MELANOMA TREATMENTS.
HW589825 - JP 2013121348-A/356: MICRORNA FINGERPRINTS DURING HUMAN MEGAKARYOCYTOPOIESIS.
HW669843 - JP 2013537538-A/574: THERAPEUTIC USES OF MICROVESICLES AND RELATED MICRORNAS.
HW913406 - JP 2015504307-A/166: METHODS OF DIAGNOSING AND TREATING IDIOPATHIC PULMONARY FIBROSIS.
HZ074020 - JP 2013535982-A/111: Single-Stranded RNAi Agents Containing an Internal, Non-Nucleic Acid Spacer.
HZ082744 - JP 2015513906-A/101: Stem Cell Microparticles.
HZ157710 - JP 2015130862-A/534: Micromirs.
HZ186557 - JP 2015146814-A/306: Oligonucleotides for modulating target RNA activity.
HZ376551 - WO 2015133521-A/3: New RNA sequence exhibiting anti-tumor effect.
HZ413629 - JP 2014060993-A/356: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HZ432168 - JP 2014207909-A/101: Micro-RNA Scaffolds and Non-Naturally Occurring Micro-RNAS.
HZ436525 - JP 2015529450-A/101: Stem Cell Microparticles.
HZ466303 - JP 2015531594-A/6: METHODS OF GENERATING MESENCHYMAL STEM CELLS WHICH SECRETE NEUROTROPHIC FACTORS.
HZ480235 - JP 2015535430-A/741: TERMINALLY MODIFIED RNA.
HZ501840 - JP 2016025853-A/356: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HZ790166 - JP 2016504050-A/1911: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
JA287356 - Sequence 38 from Patent WO2011015720.
JA401191 - Sequence 438 from Patent WO2011080318.
JA402169 - Sequence 438 from Patent WO2011080315.
JA403176 - Sequence 438 from Patent WO2011080316.
JA405807 - Sequence 438 from Patent EP2336353.
JA427139 - Sequence 472 from Patent WO2011072177.
JA429333 - Sequence 438 from Patent WO2011095623.
JA483461 - Sequence 96 from Patent EP2283161.
JA526206 - Sequence 356 from Patent EP2369011.
JA526713 - Sequence 356 from Patent EP2369012.
JA527220 - Sequence 356 from Patent EP2369013.
JA536149 - Sequence 356 from Patent EP2371971.
JA660765 - Sequence 219 from Patent WO2011131354.
JA667970 - Sequence 49 from Patent WO2011139911.
JA682630 - Sequence 98 from Patent WO2011149354.
JA715156 - Sequence 938 from Patent EP2401406.
JA729546 - Sequence 5 from Patent EP2403527.
JA781917 - Sequence 28 from Patent EP2513307.
JA788154 - Sequence 356 from Patent EP2479285.
JA788652 - Sequence 356 from Patent EP2479286.
JA792094 - Sequence 143 from Patent WO2012089753.
JA810986 - Sequence 356 from Patent EP2468890.
JA811484 - Sequence 356 from Patent EP2468891.
JA811982 - Sequence 356 from Patent EP2468893.
JA812480 - Sequence 356 from Patent EP2468894.
JA812978 - Sequence 356 from Patent EP2468895.
JA813476 - Sequence 356 from Patent EP2468896.
JA813974 - Sequence 356 from Patent EP2468897.
JA814472 - Sequence 356 from Patent EP2468898.
JA814970 - Sequence 356 from Patent EP2468899.
JA817213 - Sequence 356 from Patent EP2468892.
JA826025 - Sequence 356 from Patent EP2471956.
JA826523 - Sequence 356 from Patent EP2471958.
JB024810 - Sequence 356 from Patent EP2505668.
JB025308 - Sequence 356 from Patent EP2505669.
JB029510 - Sequence 34 from Patent EP2481805.
JB029570 - Sequence 34 from Patent EP2481806.
JB079695 - Sequence 356 from Patent EP2487252.
JB080193 - Sequence 356 from Patent EP2487253.
JB080691 - Sequence 356 from Patent EP2487254.
JB081189 - Sequence 356 from Patent EP2487255.
JB081687 - Sequence 356 from Patent EP2487256.
JB082185 - Sequence 356 from Patent EP2487257.
JB082683 - Sequence 356 from Patent EP2487258.
JB083181 - Sequence 356 from Patent EP2487259.
JB083679 - Sequence 356 from Patent EP2487260.
JB084177 - Sequence 356 from Patent EP2487261.
JB084675 - Sequence 356 from Patent EP2487262.
JB085173 - Sequence 356 from Patent EP2487263.
JB087851 - Sequence 356 from Patent EP2502630.
JB148055 - Sequence 356 from Patent EP2484782.
JB148553 - Sequence 356 from Patent EP2484783.
JB149199 - Sequence 274 from Patent EP2455486.
JB153278 - Sequence 356 from Patent EP2514433.
JB153776 - Sequence 356 from Patent EP2514434.
JB233508 - Sequence 40 from Patent EP2437750.
JB256159 - Sequence 78 from Patent EP2327710.
JB387960 - Sequence 1 from Patent WO2012041959.
JB616197 - Sequence 27 from Patent WO2013107459.
JB620043 - Sequence 23 from Patent WO2013063544.
JB620195 - Sequence 175 from Patent WO2013063544.
JB622365 - Sequence 356 from Patent EP2586454.
JB622863 - Sequence 356 from Patent EP2586455.
JB624150 - Sequence 34 from Patent EP2610347.
JB624270 - Sequence 90 from Patent EP2610342.
JB778787 - Sequence 166 from Patent WO2013078283.
JC001926 - Sequence 356 from Patent EP2591794.
JC032749 - Sequence 21 from Patent WO2013160474.
JC037524 - Sequence 52 from Patent EP2643479.
JC171729 - Sequence 101 from Patent WO2013150303.
JC244446 - Sequence 66 from Patent WO2012020308.
JC244894 - Sequence 522 from Patent WO2012020308.
JC270183 - Sequence 574 from Patent WO2012020307.
JC512898 - Sequence 3151 from Patent WO2014113089.
JC572032 - Sequence 46 from Patent EP2759595.
JC572540 - Sequence 101 from Patent WO2014125276.
JC582228 - Sequence 101 from Patent WO2014125277.
JE867391 - Sequence 198 from Patent WO2015128671.
JE953924 - Sequence 101 from Patent WO2015052526.
JE955677 - Sequence 101 from Patent WO2015052527.
JE978774 - Sequence 219 from Patent EP2865765.
LF132481 - JP 2016506923-A/46: Composition comprising an encapsulated antagomir.
LF137429 - JP 2016507550-A/101: Method of Producing Microparticles.
LF161760 - JP 2016513950-A/1826: Oligomers with improved off-target profile.
LF162394 - JP 2016513095-A/101: Stem Cell Microparticles and miRNA.
LF636310 - JP 2016519076-A/84: COMBINATION CANCER TREATMENTS UTILIZING MICRORNA AND EGFR-TKI INHIBITORS.
LF953146 - JP 2016534103-A/101: Stem Cell Microparticles and miRNA.
LG005491 - KR 1020150004822-A/101: STEM CELL MICROPARTICLES.
LG046505 - KR 1020150023687-A/50: Oligonucleotide-Based Inhibitors Comprising Locked Nucleic Acid Motif.
LG053187 - KR 1020150059168-A/101: STEM CELL MICROPARTICLES.
LG134467 - KR 1020150131312-A/84: COMBINATION CANCER TREATMENTS UTILIZING MICRORNAS AND EGFR-TKI INHIBITORS.
LG162345 - KR 1020160018451-A/46: Composition comprising an encapsulated antagomir.
LG240426 - KR 1020160035087-A/101: STEM CELL MICROPARTICLES AND MIRNA.
LP010710 - Sequence 15 from Patent EP2977463.
LP726723 - Sequence 417 from Patent EP2883966.
LP818993 - Sequence 417 from Patent EP3296406.
LP884025 - Sequence 3 from Patent WO2017167934.
LP884035 - Sequence 13 from Patent WO2017167934.
LP938935 - Sequence 417 from Patent EP3184651.
LP951818 - Sequence 324 from Patent WO2017157650.
LP973065 - Sequence 11 from Patent EP3216869.
LQ070486 - Sequence 810 from Patent EP2964234.
LQ417665 - Sequence 1 from Patent WO2016125163.
LQ754445 - Sequence 23 from Patent EP3329005.
LQ840940 - Sequence 50 from Patent EP3354734.
LV470511 - JP 2016534036-A/101: Stem Cell Microparticles and miRNA.
LV539153 - JP 2016539127-A/154: C/EBP ALPHA COMPOSITIONS AND METHODS OF USE.
LV746125 - JP 2015521626-A/50: OLIGONUCLEOTIDE-BASED INHIBITORS COMPRISING LOCKED NUCLEIC ACID MOTIF.
LX154550 - JP 2017509333-A/198: Biomarkers for Endometriosis.
LX270640 - JP 2016056210-A/574: THERAPEUTIC USES OF MICROVESICLES AND RELATED MICRORNAS.
LY298555 - KR 1020160079824-A/154: C/EBP ALPHA SHORT ACTIVATING RNA COMPOSITIONS AND METHODS OF USE.
LY405218 - KR 1020160117535-A/523: POLY OLIGOMER COMPOUND WITH BIOCLEAVABLE CONJUGATES.
LY416904 - KR 1020160145093-A/10: USE OF MICRO-RIBONUCLEIC ACID(MIRNA) TO DIAGNOSE TRANSPLANT REJECTION AND TOLERANCE OF IMMUNOSUPPRESSION THERAPY.
LY504787 - KR 1020170035932-A/176: MICRORNA BIOMARKER FOR THE DIAGNOSIS OF GASTRIC CANCER.
LZ233914 - JP 2017184756-A/306: Oligonucleotides for modulating target RNA activity.
LZ243068 - JP 2017525350-A/176: MICRORNA BIOMARKER FOR THE DIAGNOSIS OF GASTRIC CANCER.
LZ986415 - JP 2017225396-A/17: Complex and use thereof.
LZ991536 - WO 2017221875-A/17: COMPLEX AND USE THEREOF.
MA260457 - JP 2017505623-A/523: POLY OLIGOMER COMPOUND WITH BIOCLEAVABLE CONJUGATES.
MS816745 - Sequence 94 from Patent WO2017085287.
MS833385 - Sequence 90 from Patent EP3112464.
MS834292 - Sequence 438 from Patent EP3112479.
MS944920 - Sequence 176 from Patent EP3177739.
MP174434 - Sequence 19 from Patent WO2019058253.
MP129503 - Sequence 403 from Patent EP3470073.
MP162124 - Sequence 101 from Patent WO2019069093.
MP162426 - Sequence 403 from Patent WO2019069093.
MP129201 - Sequence 101 from Patent EP3470073.
MA643986 - JP 2017113010-A/1910: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
MA731870 - JP 2017140048-A/740: TERMINALLY MODIFIED RNA.
MA643987 - JP 2017113010-A/1911: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
MA730787 - JP 2017125065-A/574: THERAPEUTIC USES OF MICROVESICLES AND RELATED MICRORNAS.
MA731871 - JP 2017140048-A/741: TERMINALLY MODIFIED RNA.
MA783867 - WO 2018181877-A/8: Anti-cancer agent using miRNA.
MA784178 - WO 2018194089-A/1: GENE-MODIFIED COXSACKIEVIRUS AND PHARMACEUTICAL COMPOSITION.
LQ938809 - Sequence 3 from Patent EP2774990.
LQ938810 - Sequence 4 from Patent EP2774990.
LQ932799 - Sequence 23 from Patent EP2802207.
MA405579 - WO 2018155427-A/353: A probe with reduced false positive binding, a method to desing the probe, and the use thereof.
MA419982 - JP 2018518169-A/33: NON-ALCOHOLIC FATTY LIVER DISEASE BIOMARKERS.
MA420006 - JP 2018518169-A/57: NON-ALCOHOLIC FATTY LIVER DISEASE BIOMARKERS.
MA420023 - JP 2018518169-A/74: NON-ALCOHOLIC FATTY LIVER DISEASE BIOMARKERS.
MA420059 - JP 2018518169-A/110: NON-ALCOHOLIC FATTY LIVER DISEASE BIOMARKERS.
MA420090 - JP 2018518169-A/141: NON-ALCOHOLIC FATTY LIVER DISEASE BIOMARKERS.
MA420107 - JP 2018518169-A/158: NON-ALCOHOLIC FATTY LIVER DISEASE BIOMARKERS.
MA420132 - JP 2018518169-A/183: NON-ALCOHOLIC FATTY LIVER DISEASE BIOMARKERS.
MA420163 - JP 2018518169-A/214: NON-ALCOHOLIC FATTY LIVER DISEASE BIOMARKERS.
MA420183 - JP 2018518169-A/234: NON-ALCOHOLIC FATTY LIVER DISEASE BIOMARKERS.
MA625402 - JP 2018138044-A/8: METHODS OF GENERATING MESENCHYMAL STEM CELLS WHICH SECRETE NEUROTROPHIC FACTORS.
MA625400 - JP 2018138044-A/6: METHODS OF GENERATING MESENCHYMAL STEM CELLS WHICH SECRETE NEUROTROPHIC FACTORS.
MP065922 - Sequence 36 from Patent WO2018228875.
MP065923 - Sequence 37 from Patent WO2018228875.
MP075720 - Sequence 59 from Patent WO2019002265.
MP070429 - Sequence 26 from Patent WO2018231851.
MP075662 - Sequence 1 from Patent WO2019002265.
MP075676 - Sequence 15 from Patent WO2019002265.
MP075721 - Sequence 60 from Patent WO2019002265.
MA801039 - JP 2018183181-A/1910: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
MA801040 - JP 2018183181-A/1911: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
MA820033 - JP 2018534542-A/3: METHODS FOR DIAGNOSING AND EVALUATING NON-ALCOHOLIC STEATOHEPATITIS.
MA886369 - WO 2019049612-A/9: An antitumor agent, food and beverage for prevention of cancer and an agent for increasing expression of tumor-suppressive microRNA.
MA896107 - JP 2017217007-A/50: OLIGONUCLEOTIDE-BASED INHIBITORS COMPRISING LOCKED NUCLEIC ACID MOTIF.
MP280637 - Sequence 57 from Patent WO2019111197.
MP264454 - Sequence 42 from Patent EP3502269.
MP280638 - Sequence 58 from Patent WO2019111197.
MP283550 - Sequence 57 from Patent WO2019111198.
MP272074 - Sequence 22 from Patent WO2019157381.
MP283551 - Sequence 58 from Patent WO2019111198.
LY628288 - KR 1020180132092-A/3: NON-INVASIVE DIAGNOSTIC OF NON-ALCOHOLIC STEATOHEPATITIS.
LY628298 - KR 1020180132092-A/13: NON-INVASIVE DIAGNOSTIC OF NON-ALCOHOLIC STEATOHEPATITIS.
LY581972 - KR 1020180120565-A/1: Method of providing the information for selecting the drugs for treating EML4-ALK positive non-small-cell lung cancer resistant to ALK inhibitors.

-  Other Names for This Gene
  Alternate Gene Symbols: EF609116
UCSC ID: uc009vmq.3
Representative RNA: EF609116

-  Gene Model Information
 
category: coding nonsense-mediated-decay: no RNA accession: EF609116.1
exon count: 2CDS single in 3' UTR: no RNA size: 563
ORF size: 393CDS single in intron: no Alignment % ID: 100.00
txCdsPredict score: 917.00frame shift in genome: no % Coverage: 100.00
has start codon: yes stop codon in genome: no # of Alignments: 1
has end codon: yes retained intron: no # AT/AC introns 0
selenocysteine: no end bleed into intron: 0# strange splices: 0
Click here for a detailed description of the fields of the table above.

-  Methods, Credits, and Use Restrictions
  Click here for details on how this gene model was made and data restrictions if any.